| (P1626) |
Characteristics and clinical associations of late gadolinium enhanced cardiac magnetic resonance in lamin A/C, cardiac troponin T and myosin binding protein C gene mutation related cardiomyopathies |
|
A. Santosa, J. Franke, D. Schmahl, B. Meder, R. Pribe, P. Ehlermann, G. Kopietz, H. Steen, G. Korosoglou, H. A. Katus (Heidelberg) |
| (P1627) |
Prognostic value of cardiac magnetic resonance imaging in patients with left ventricular noncompaction |
|
B. Schneider, T. Hümme, U. Desch, H. Vorbringer (Lübeck) |
| (P1628) |
Muskelbrücken sind mit einem apikalen Ballooning und linksventrikulären Thromben assoziiert – Ergebnisse des ALKK Tako-tsubo Registers |
|
A. Athanasiadis, B. Schneider, W. Pistner, R. Schoeller, C. Stellbrink, W. Kasper, J. Schwab, W. von Scheidt, U. Sechtem (Stuttgart, Lübeck, Aschaffenburg, Berlin, Bielefeld, Wiesbaden, Nürnberg, Augsburg) |
| (P1629) |
Prevalence and clinical significance of giant negative T-waves in patients with tako-tsubo cardiomyopathy |
|
B. Schneider, U. Desch, J. Stein (Lübeck) |
| (P1630) |
Autonomic Dysfunction in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: Biochemical Evidence of Altered Signaling Pathways |
|
M. Paul, M. Meyborg, P. Boknik, U. Gergs, J. Gerß, G. Breithardt, J. Neumann, T. Wichter (Münster, Halle/Saale, Osnabrück) |
| (P1631) |
QRS fragmentation in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and complete right bundle branch block. |
|
S. Peters (Gronau) |
| (P1632) |
Long-term Outcome of Percutaneous Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy |
|
C. Prinz, M. Schumann, A. Burghardt, H. Seggewiß, O. Oldenburg, D. Horstkotte, L. Faber (Bad Oeynhausen, Schweinfurt) |
| (P1633) |
Langzeit Follow-up von 99 Patienten nach Transkoronarer Alkoholablation (TASH) bei HOCM: Kein Anhalt für erhöhtes arrythmogenes Risiko |
|
T. Lawrenz, M. Schlößer, C. Leuner, S. Gottschalk, C. Stellbrink, H. Kuhn (Witten, Bielefeld) |
| (P1634) |
Prevalence and prognostic impact of the BMP-antagonist Gremlin in endomyocardial biopsies of patients with acute onset cardiomyopathy |
|
K. A. L. Müller, C. S. Zürn, T. Geisler, R. Kandolf, M. Gawaz, I. I. Müller (Tübingen) |
| (P1635) |
Exome sequencing of a family with dilated cardiomyopathy |
|
U. Esslinger, C. Meindl, E. Villard, C. Perret, F. Cambien, K. Stark, C. Hengstenberg (Regensburg; Paris, FR) |
| (P1636) |
Identifizierung von Missense-Mutationen in der dritten Immunglobulin-ähnlichen Domäne des Z-Scheiben-Proteins Myopalladin bei Patienten mit dilatativer Kardiomyopathie |
|
V. Ruppert, T. Meyer, A. Richter, B. Maisch, S. Pankuweit und KNHI (Marburg, Göttingen) |
| (P1637) |
Mutations in MYOM2 encoding for the M-band protein myomesin 2 in patients with hypertrophic cardiomyopathy – a novel disease gene for cardiomyopathies? |
|
A. Perrot, A. Barton, B. Kherad, F. Blaschke, F. C. Luft, L.-H. Boldt, W. Haverkamp (Berlin) |
| (P1638) |
Familial Hypertrophic Cardiomyopathy related ß-myosin mutation R723G: primary functional effects are masked in human cardiomyocytes by (mal)adaptational processes. |
|
T. Kraft, S. Tripathi, A. Francino, F. Navarro-Lopez, B. Brenner, G. Stienen, J. van der Velden (Hannover; Barcelona, ES; Amsterdam, NL) |